Abiopharma

🔍 Abraham Spencer (Director)

Company: URANIUM ENERGY CORP (UEC)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 1,623 shares of Options (right to buy) at $11.21 per share (Derivative)
  Date: 2026-08-14 | Code: A | Expires: 2036-08-14 | equity_swap_involved: 0 | shares_owned_after: 1,623.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,015 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 35,883.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Options vest over a 24-month period (12.5% three and six months from the date of grant; and 25% 12, 18 and 24 months from the date of grant).
• F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of the Issuer's common stock.
• F3: The Restricted Stock Units vest in three equal annual installments beginning July 31, 2027, subject to continued Board service through the applicable vesting date. Vested shares will be delivered to the reporting person no later than August 30th of each year.